Acne Clearning Treatment
NDC Package 51439-007-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Acne Clearning Treatment is directions:Acne Clearing CleanserAcne Clearing TonicAcne Clearing Treatment 101. Marketed by Carepluss Pharma S.a. De C.v., this product is identified by NDC 51439-007 and is authorized under FDA application part333D.

Identification & Billing

NDC Package Code
51439-007-02
Package Description
3 BOTTLE in 1 BOX / .024 mg in 1 BOTTLE (51439-007-01)
Product Code
51439-007
11-Digit Billing Format
51439000702
RxNorm Crosswalk
  • RxCUI: 1372925 - {1 (240 ML) (benzoyl peroxide 25 MG/ML Medicated Liquid Soap) / 1 (120 ML) (salicylic acid 20 MG/ML Topical Solution) / 1 (60 ML) (sulfur 50 MG/ML Topical Solution) } Pack
  • RxCUI: 1372925 - benzoyl peroxide 2.5 % Medicated Liquid Soap (240 ML) / salicylic acid 2 % Topical Solution (120 ML) / sulfur 5 % Topical Solution (60 ML) Pack
  • RxCUI: 1372925 - {1 (240 ML) (benzoyl peroxide 2.5 % Medicated Liquid Soap) / 1 (120 ML) (salicylic acid 2 % Topical Solution) / 1 (60 ML) (sulfur 5 % Topical Solution) } Pack
  • RxCUI: 251577 - salicylic acid 2 % Topical Solution
  • RxCUI: 251577 - salicylic acid 20 MG/ML Topical Solution

Clinical Specifications

Proprietary Name
Acne Clearning Treatment Face
Dosage Form
-
Usage Information
Directions:Acne Clearing CleanserAcne Clearing TonicAcne Clearing Treatment 101

Regulatory & Marketing

Labeler Name
Carepluss Pharma S.a. De C.v.
FDA Application #
part333D
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
08-06-2012
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51439-007-02 identifies a specific commercial package of 3 bottle in 1 box / .024 mg in 1 bottle (51439-007-01) of Acne Clearning Treatment Face, labeled by Carepluss Pharma S.a. De C.v.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Carepluss Pharma S.a. De C.v. on August 06, 2012. The current certification is valid through December 31, 2017.

How is this Carepluss Pharma S.a. De C.v. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51439000702. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51439-007-02
11-Digit CMS (5-4-2)
51439-0007-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.